GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.00+0.08 (+4.17%)
Close on Nov 17, 2026Market cap $90.49MP/E –Yield –
Genelux enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Genelux's enterprise value was $66.11M on Nov 11, 2026, against $190.63M a year earlier. Over the last 4 years it ranged from $33.02M to $793.95M, with a median of $105.66M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $66.11M | -54.4% |
| 2025 | Dec 31, 2025 | $144.97M | +212.1% |
| 2024 | Dec 31, 2024 | $46.45M | -86.5% |
| 2023 | Dec 29, 2023 | $344.51M | – |
See a number that looks wrong?